Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-06-27

Clinical Trial Update: The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effects of short-term exenatide therapy in newly diagnosed Type 2 diabetes mellitus patients, sponsored by Taipei Ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN